Canada Pension Plan Investment Board Novartis Ag Transaction History

Canada Pension Plan Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $56.2 Million - $65.2 Million	606,890 New	606,890 $64.6 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $4.12 Million - $4.57 Million	-50,177 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $4.06 Million - $4.57 Million	50,177 New	50,177 $4.38 Million
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $1.03 Million - $1.26 Million	-13,600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $2.74 Million - $3.14 Million	-36,400 Reduced 72.8%	13,600 $1.31 Million
Q4 2018 Feb 06, 2019	BUY	$73.66 - $82.02 $3.68 Million - $4.1 Million	50,000 New	50,000 $4.29 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.